Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Carcinoma, Basal Cell × remetinostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Squamous Cell 1 Carcinoma, Basal Cell 1

Interventions

HhAntag691 12 sonidegib 4 methyl 5-aminolevulinate 3 Photochemotherapy 3 Aminolevulinic Acid 3 tazarotene 2 IPI-926 2 Drug Evaluation 2 1-phenyl-3,3-dimethyltriazene 2 remetinostat 1 pembrolizumab 1 cemiplimab 1 Risk Factors 1 NVP-BKM120 1 Mindfulness 1 Midazolam 1 IFL protocol 1 Folfox protocol 1 Blood Specimen Collection 1 Bevacizumab 1 BF-200 ALA 1 Arsenic Trioxide 1 Anesthesia, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03180528 2021-06-08

Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer

Stanford University

Phase 2 Completed

30 enrolled 10 charts

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡